Mérieux Equity Partners

Mérieux Equity Partners, established in 2009 and headquartered in Lyon, France, is a private equity firm focused on venture, growth, and LBO investments in the healthcare and nutrition sectors. The company actively supports entrepreneurs and industrial companies with innovative products and services, providing access to its expertise and international network. As of now, Mérieux Equity Partners manages over €600 million in assets under management, with a recent fund, MP3, dedicated to growth and LBO investments totaling €350 million.

Pierre-Adrien Ausset

Associate

Romain Blache

Analyst

Yoann Bonnamour

Director

Yoann Bonnamour

Director

Valerie Calenda

Managing Partner

Christine Demode

President, Head of Operations

Jonathan Dupont

Associate

Quentin De Labarre

Director

Marie-Justine Lecomte

Director

Guillaume Martignoni

Associate

Kristin Thompson Ph.D

Investment Director

Guillaume Thoviste

Associate

Jérémie Waicenberg

Investment Manager

Theodor Wuppermann

Managing Director

Past deals in Slovenia

Swixx Biopharma

Venture Round in 2021
Swixx Biopharma is a specialized company that provides comprehensive representation for biopharma, over-the-counter (OTC), and medical device firms in Central and Eastern Europe (CEE). Founded in 2014 and based in Baar, Switzerland, Swixx Biopharma operates fully-owned affiliates across various CEE countries, including Albania, Bulgaria, Poland, and Romania, among others. The company aims to fill the gap left by multinational corporations that choose not to enter or exit specific markets or therapeutic areas. With a focus on rare diseases, oncology-hematology, specialty treatments, and self-medication, Swixx Biopharma leverages its research expertise to deliver effective health solutions tailored to the needs of the region.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.